AZN - AstraZeneca PLC

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5121.24B
Enterprise Value 3134.02B
Trailing P/E 52.78
Forward P/E 122.48
PEG Ratio (5 yr expected) 11.58
Price/Sales (ttm)5.26
Price/Book (mrq)8.74
Enterprise Value/Revenue 35.81
Enterprise Value/EBITDA 625.68

Trading Information

Stock Price History

Beta (3Y Monthly) 0.43
52-Week Change 317.86%
S&P500 52-Week Change 32.99%
52 Week High 345.69
52 Week Low 335.30
50-Day Moving Average 344.29
200-Day Moving Average 341.28

Share Statistics

Avg Vol (3 month) 33.21M
Avg Vol (10 day) 34.6M
Shares Outstanding 52.62B
Float 2.61B
% Held by Insiders 10.01%
% Held by Institutions 119.37%
Shares Short (Aug 15, 2019) 414.29M
Short Ratio (Aug 15, 2019) 44.28
Short % of Float (Aug 15, 2019) 4N/A
Short % of Shares Outstanding (Aug 15, 2019) 40.59%
Shares Short (prior month Jul 15, 2019) 411.57M

Dividends & Splits

Forward Annual Dividend Rate 41.4
Forward Annual Dividend Yield 43.14%
Trailing Annual Dividend Rate 32.80
Trailing Annual Dividend Yield 36.28%
5 Year Average Dividend Yield 44.15
Payout Ratio 4162.79%
Dividend Date 3Sep 9, 2019
Ex-Dividend Date 4Aug 8, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jul 27, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 9.48%
Operating Margin (ttm)10.74%

Management Effectiveness

Return on Assets (ttm)2.51%
Return on Equity (ttm)14.21%

Income Statement

Revenue (ttm)23.07B
Revenue Per Share (ttm)9.03
Quarterly Revenue Growth (yoy)13.00%
Gross Profit (ttm)17.59B
EBITDA 5.22B
Net Income Avi to Common (ttm)2.19B
Diluted EPS (ttm)0.86
Quarterly Earnings Growth (yoy)-62.90%

Balance Sheet

Total Cash (mrq)6.25B
Total Cash Per Share (mrq)2.38
Total Debt (mrq)21.77B
Total Debt/Equity (mrq)144.48
Current Ratio (mrq)0.95
Book Value Per Share (mrq)5.17

Cash Flow Statement

Operating Cash Flow (ttm)3.18B
Levered Free Cash Flow (ttm)5.46B